Rational Use of Danofloxacin for Treatment of <i>Mycoplasma gallisepticum</i> in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift

The study was to explore the rational use of danofloxacin against <i>Mycoplasma gallisepticum</i> (<i>MG</i>) based on its clinical breakpoint (CBP) and the effect on lung microbiota. The CBP was established according to epidemiological cutoff value (ECV/CO_WT), pharmacokinetic–pharmacodyn...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Shuge Wang, Anxiong Huang, Yufeng Gu, Jun Li, Lingli Huang, Xu Wang, Yanfei Tao, Zhenli Liu, Congming Wu, Zonghui Yuan, Haihong Hao
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-03-01
Schriftenreihe:	Antibiotics
Schlagworte:	danofloxacin <i>Mycoplasma gallisepticum</i> epidemiological cutoff values PK–PD cutoff values clinical cutoff values clinical breakpoint
Online-Zugang:	https://www.mdpi.com/2079-6382/11/3/403
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!